Np mrd loader

Record Information
Version2.0
Created at2022-04-27 22:37:25 UTC
Updated at2022-04-27 22:37:25 UTC
NP-MRD IDNP0051231
Secondary Accession NumbersNone
Natural Product Identification
Common NameHydroquinidine
DescriptionHydroquinidine, also known as LCN 834 or lentoquine, belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]Octane moiety. Hydroquinidine is found in Aspidosperma marcgravianum, Cinchona officinalis and Remijia pedunculata. Hydroquinidine was first documented in 2019 (PMID: 31441080). Based on a literature review a small amount of articles have been published on hydroquinidine (PMID: 35467248) (PMID: 33324992) (PMID: 32025785) (PMID: 31930659).
Structure
Thumb
Synonyms
ValueSource
LCN 834MeSH
LCN-834MeSH
LentoquineMeSH
SérécorMeSH
DihydroquinidineMeSH
DihydroquinineMeSH
Hydroquinidine dihydrochloride, (1beta,4beta,3S)-(+-)-isomerMeSH
Hydroquinidine dihydrochloride, (3alpha,9S)-(+-)-isomerMeSH
Hydroquinidine hydrochlorideMeSH
Hydroquinidine monosulfateMeSH
Hydroquinidine monosulfate, (1beta,3alpha,4beta,8alpha,9R)-isomerMeSH
Hydroquinidine monosulfate, (1beta,3alpha,4beta,9S)-isomerMeSH
Hydroquinidine sulfateMeSH
Hydroquinidine sulfate, (9S)-isomerMeSH
Hydroquinidine, (+-)-isomerMeSH
Hydroquinidine, (1beta, 3alpha,4beta,8alpha,9R)-isomerMeSH
Hydroquinidine, (1beta,3alpha,4beta,9S)-isomerMeSH
Hydroquinidine, (1beta,4beta,9S)-(+-)-isomerMeSH
Hydroquinidine, (3alpha,9S)-(+-)-isomerMeSH
Hydroquinidine, (8alpha,9R)-isomerMeSH
Hydroquinidine, (8alpha,9S)-isomerMeSH
Hydroquinidine, (9R)-isomerMeSH
Hydroquinidine, (9S)-(+-)-isomerMeSH
HydroquinineMeSH
Chemical FormulaC20H26N2O2
Average Mass326.4400 Da
Monoisotopic Mass326.19943 Da
IUPAC Name(S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol
Traditional Name(S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol
CAS Registry NumberNot Available
SMILES
CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
InChI Identifier
InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19+,20-/m0/s1
InChI KeyLJOQGZACKSYWCH-LHHVKLHASA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Aspidosperma marcgravianumPlant
Cinchona officinalisPlant
Remijia pedunculataPlant
Chemical Taxonomy
Description Belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]Octane moiety.
KingdomOrganic compounds
Super ClassAlkaloids and derivatives
ClassCinchona alkaloids
Sub ClassNot Available
Direct ParentCinchona alkaloids
Alternative Parents
Substituents
  • Cinchonan-skeleton
  • 4-quinolinemethanol
  • Quinoline
  • Anisole
  • Quinuclidine
  • Alkyl aryl ether
  • Aralkylamine
  • Piperidine
  • Pyridine
  • Benzenoid
  • Heteroaromatic compound
  • 1,2-aminoalcohol
  • Tertiary aliphatic amine
  • Tertiary amine
  • Secondary alcohol
  • Ether
  • Azacycle
  • Organoheterocyclic compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Amine
  • Alcohol
  • Organic oxygen compound
  • Aromatic alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.36ALOGPS
logP2.82ChemAxon
logS-3ALOGPS
pKa (Strongest Acidic)13.89ChemAxon
pKa (Strongest Basic)9.18ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area45.59 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity94.65 m³·mol⁻¹ChemAxon
Polarizability36.67 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00002173
Chemspider ID82624
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkDihydroquinidine
METLIN IDNot Available
PubChem Compound91503
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Katis G, Wiles B, Saba MM: Short-coupled ventricular ectopics leading to cardiac arrest in a young woman. Egypt Heart J. 2022 Apr 25;74(1):32. doi: 10.1186/s43044-022-00272-y. [PubMed:35467248 ]
  2. Steinfurt J, Bezzina CR, Biermann J, Staudacher D, Marschall C, Trolese L, Faber TS, Duerschmied D, Zehender M, Bode C, Wilde AAM, Odening KE, Lodder EM: Two siblings with early repolarization syndrome: clinical and genetic characterization by whole-exome sequencing. Europace. 2021 May 21;23(5):775-780. doi: 10.1093/europace/euaa357. [PubMed:33324992 ]
  3. Horn N, Rub N, Wolpert C: [Long and short QT syndromes : Emergency treatment and secondary prophylaxis]. Herzschrittmacherther Elektrophysiol. 2020 Mar;31(1):48-54. doi: 10.1007/s00399-020-00666-y. Epub 2020 Feb 5. [PubMed:32025785 ]
  4. Doisne N, Waldmann V, Redheuil A, Waintraub X, Fressart V, Ader F, Fosse L, Hidden-Lucet F, Gandjbakhch E, Neyroud N: A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions. Hum Mutat. 2020 Apr;41(4):850-859. doi: 10.1002/humu.23981. Epub 2020 Jan 25. [PubMed:31930659 ]
  5. El-Battrawy I, Roterberg G, Liebe V, Ansari U, Lang S, Zhou X, Borggrefe M, Akin I: Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up. Clin Cardiol. 2019 Oct;42(10):958-965. doi: 10.1002/clc.23247. Epub 2019 Aug 22. [PubMed:31441080 ]